Kashif Asghar

594 total citations
29 papers, 479 citations indexed

About

Kashif Asghar is a scholar working on Biological Psychiatry, Oncology and Molecular Biology. According to data from OpenAlex, Kashif Asghar has authored 29 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biological Psychiatry, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Kashif Asghar's work include Tryptophan and brain disorders (14 papers), Stress Responses and Cortisol (5 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). Kashif Asghar is often cited by papers focused on Tryptophan and brain disorders (14 papers), Stress Responses and Cortisol (5 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). Kashif Asghar collaborates with scholars based in Pakistan, Australia and United States. Kashif Asghar's co-authors include Shahzina Kanwal, Rai Khalid Farooq, Asim V. Farooq, Bilal Zulfiqar, Muhammad Usman Rashid, Nasir Jalal, Asif Loya, Marie Rimbert, Séverine Remy and Pierre‐Joseph Royer and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Immunology and Gene.

In The Last Decade

Kashif Asghar

27 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kashif Asghar Pakistan 11 207 128 123 106 80 29 479
Yi-Shu Huang United Kingdom 10 138 0.7× 239 1.9× 139 1.1× 86 0.8× 48 0.6× 15 536
Tang Jiang China 11 147 0.7× 112 0.9× 71 0.6× 114 1.1× 17 0.2× 21 415
Margaret A. Jordan Australia 16 111 0.5× 162 1.3× 404 3.3× 85 0.8× 90 1.1× 32 822
A Watzlik Germany 4 444 2.1× 138 1.1× 372 3.0× 209 2.0× 84 1.1× 5 801
Guang-Xian Zhang United States 5 133 0.6× 74 0.6× 344 2.8× 63 0.6× 89 1.1× 6 564
J F Attrep United States 8 54 0.3× 80 0.6× 224 1.8× 64 0.6× 55 0.7× 8 563
Niamh Clarke Ireland 14 63 0.3× 112 0.9× 117 1.0× 48 0.5× 104 1.3× 24 518
Thomas M. Bauer Germany 7 592 2.9× 215 1.7× 499 4.1× 276 2.6× 110 1.4× 7 1.1k
M. Rieks Germany 7 40 0.2× 113 0.9× 102 0.8× 56 0.5× 64 0.8× 9 453
Gwen S. Rees United Kingdom 11 55 0.3× 173 1.4× 98 0.8× 74 0.7× 35 0.4× 14 461

Countries citing papers authored by Kashif Asghar

Since Specialization
Citations

This map shows the geographic impact of Kashif Asghar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kashif Asghar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kashif Asghar more than expected).

Fields of papers citing papers by Kashif Asghar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kashif Asghar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kashif Asghar. The network helps show where Kashif Asghar may publish in the future.

Co-authorship network of co-authors of Kashif Asghar

This figure shows the co-authorship network connecting the top 25 collaborators of Kashif Asghar. A scholar is included among the top collaborators of Kashif Asghar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kashif Asghar. Kashif Asghar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fatima, Munazza, Alamgeer Umme Habiba Hasan, Muhammad Jawad Hassan, et al.. (2025). Expression of immune checkpoints (IDO and PD-L1) in oral tongue cancer patients: a 10-year retrospective cohort study in Pakistan. Frontiers in Oncology. 15. 1495722–1495722. 1 indexed citations
2.
Farooq, Asim V., et al.. (2025). Evaluation of Indoleamine 2,3-Dioxygenase (IDO) Expression in Osteosarcoma: Insights From a 10-Year Retrospective Cohort. OncoTargets and Therapy. Volume 18. 367–377. 1 indexed citations
3.
Bakar, Muhammad Abu, et al.. (2024). Survival Outcomes in Malignancy-related Hypercalcemia: A Tertiary care Single Center Experience. SHILAP Revista de lepidopterología. 10(2). 675–675.
4.
Asghar, Kashif, et al.. (2023). High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients. Asian Pacific Journal of Cancer Prevention. 24(5). 1591–1600. 1 indexed citations
5.
Asghar, Kashif, et al.. (2023). PD-L1 is Fascinating but IDO Needs Attention in Non-HCV and Non-HBV-Associated Hepatocellular Carcinoma Patients. Journal of Hepatocellular Carcinoma. Volume 10. 921–934. 2 indexed citations
6.
Asghar, Kashif, et al.. (2022). COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management. Frontiers in Oncology. 12. 922579–922579. 1 indexed citations
7.
Farooq, Asim V., Bilal Zulfiqar, & Kashif Asghar. (2022). Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma. SHILAP Revista de lepidopterología. 9(1). 501–501. 3 indexed citations
8.
Zulfiqar, Bilal, Asim V. Farooq, Shahzina Kanwal, & Kashif Asghar. (2022). Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives. Frontiers in Pharmacology. 13. 1035171–1035171. 28 indexed citations
9.
Bashir, Humayun, et al.. (2022). Efficacy of Radioiodine Therapy in Patients With Primary Hyperthyroidism: An Institutional Review From Pakistan. Cureus. 14(5). e24992–e24992. 5 indexed citations
10.
Asghar, Kashif, Muhammad Abu Bakar, Asim V. Farooq, et al.. (2021). Clinical Characteristics of COVID-19-Infected Cancer Patients in Pakistan: Differences Between Survivors and Non-Survivors. Frontiers in Oncology. 11. 655634–655634. 6 indexed citations
11.
Asghar, Kashif, Asim V. Farooq, Bilal Zulfiqar, & Asif Loya. (2021). Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase. World Journal of Clinical Oncology. 12(6). 429–436. 5 indexed citations
12.
Asghar, Kashif & Asif Loya. (2021). Establishment of biobanking facility at Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan. Cell and Tissue Banking. 23(4). 937–938. 2 indexed citations
13.
Asghar, Kashif, et al.. (2020). Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients. World Journal of Clinical Oncology. 11(12). 1018–1028. 4 indexed citations
14.
Asghar, Kashif, et al.. (2019). Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan. Asian Pacific Journal of Cancer Prevention. 20(11). 3521–3525. 6 indexed citations
15.
Asghar, Kashif, John Brain, Jeremy M. Palmer, et al.. (2017). Potential role of indoleamine 2,3‑dioxygenase in primary biliary cirrhosis. Oncology Letters. 14(5). 5497–5504. 10 indexed citations
16.
Malik, Uzma, Aneela Javed, Amjad Ali, & Kashif Asghar. (2016). Structural and functional annotation of human FAM26F: A multifaceted protein having a critical role in the immune system. Gene. 597. 66–75. 17 indexed citations
17.
Asghar, Kashif, et al.. (2014). Indoleamine 2,3-dioxygenase expression and activity in patients with hepatitis C virus-induced liver cirrhosis. Experimental and Therapeutic Medicine. 9(3). 901–904. 18 indexed citations
18.
Rashid, Muhammad Usman, et al.. (2012). Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients. Familial Cancer. 11(2). 307–311. 18 indexed citations
19.
Rashid, Muhammad Usman, Saba Khaliq, Kashif Asghar, et al.. (2011). Identification of the deleterious 2080insA BRCA1 mutation in a male renal cell carcinoma patient from a family with multiple cancer diagnoses from Pakistan. Familial Cancer. 10(4). 709–712. 8 indexed citations
20.
Hill, Marcelo, Séverine Tanguy‐Royer, Pierre‐Joseph Royer, et al.. (2007). IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS‐treated dendritic cells. European Journal of Immunology. 37(11). 3054–3062. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi-Shu Huang Breakdown of academic impact, for papers by Tang Jiang Breakdown of academic impact, for papers by Margaret A. Jordan Breakdown of academic impact, for papers by A Watzlik Breakdown of academic impact, for papers by Guang-Xian Zhang Breakdown of academic impact, for papers by J F Attrep Breakdown of academic impact, for papers by Niamh Clarke Breakdown of academic impact, for papers by Thomas M. Bauer Breakdown of academic impact, for papers by M. Rieks Breakdown of academic impact, for papers by Gwen S. Rees
Rankless by CCL
2026